Form 4: SAB Biotherapeutics Insider Sells Shares

Alexandra Kropotova, Chief Medical Officer of SAB Biotherapeutics, Inc., reported a transaction involving the withholding of shares for tax purposes.

Summary

• Alexandra Kropotova, Chief Medical Officer of SAB Biotherapeutics, Inc., engaged in a transaction on June 25, 2026.
• This transaction involved the withholding of 988 shares of common stock to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
• Following this transaction, Kropotova beneficially owns 42,308 shares of common stock.
• This ownership includes 37,158 shares of common stock and 5,150 shares that are still subject to vesting under the company's 2021 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine tax-related share withholding by an executive rather than a sale or purchase of stock that would indicate a change in investment sentiment.

Future Outlook

No specific future outlook or guidance was provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal changes in company performance or strategy. They primarily provide transparency regarding executive compensation and stock ownership.

Key Dates

Keywords

SAB Biotherapeutics, SABS, Form 4, Insider Transaction, Stock Withholding, RSU Vesting, Beneficial Ownership